Enovis (ENOV) Total Debt Growth (1y) (2011 - 2026)
Enovis (ENOV) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 19.06% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -5.76% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -2.49% |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | -4.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -4.44% |
| Dec 31, 2025 | -3.91% |
| Oct 3, 2025 | 2.53% |
| Jul 4, 2025 | 2.51% |
| Apr 4, 2025 | 2.13% |
| Dec 31, 2024 | 189.50% |
| Sep 27, 2024 | 240.63% |
| Jun 28, 2024 | 239.87% |
| Mar 29, 2024 | 376.72% |
| Dec 31, 2023 | 79.79% |
| Sep 29, 2023 | -56.04% |
| Jun 30, 2023 | -55.50% |
| Mar 31, 2023 | -88.57% |
| Dec 31, 2022 | -87.62% |
| Sep 30, 2022 | -44.75% |
| Jul 1, 2022 | -43.71% |
| Apr 1, 2022 | -15.13% |
| Dec 31, 2021 | -7.27% |
| Oct 1, 2021 | -27.59% |
| Jul 2, 2021 | -28.94% |